Collegium Pharmaceutical's Seed VC - II Round

Collegium Pharmaceutical raised a round of funding on June 20, 2005. Investors include Boston Millennia Partners.

Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chron…

Articles about Collegium Pharmaceutical's Seed VC - II Round: